Please ensure Javascript is enabled for purposes of website accessibility

Stocks Vs. Bonds for Income: Let's Rumble

By Russ Krull – Updated Apr 6, 2017 at 8:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Stocks or bonds for income?

During last week's bond blizzard, Johnson & Johnson (NYSE: JNJ) was able to issue 10-year notes with a coupon rate only a few ticks above its stock dividend yield. Not quite as impressive as last year when it sold 10-year notes yielding less than the stock, but it still sets up a scenario where Johnson & Johnson could improve its cash flow by issuing debt and using the money to buy back stock.

With the low bond yield, income investors considering Johnson & Johnson bonds should consider the stock instead.  It's very unlikely the bonds will outperform the income stream from the stock over the next 10 years, given Johnson & Johnson's history of dividend hikes.

A search at FINRA.org for high-quality, investment grade bonds with approximately 10 years until maturity turned up several issues with yields less than or close to the same company's stock dividend yield. In addition, each of the companies listed below has increased or at least maintained its dividend over the past several years, including through the financial crisis of 2008-2009.

Company

Stock Dividend Yield

Bond Maturity

Recent Bond Yield to Maturity

Abbott Laboratories (NYSE: ABT)

3.6%

05/27/20

3.81%

Colgate-Palmolive (NYSE: CL)

2.7%

11/01/20

3.43%

Conoco Phillips (NYSE: COP)

3.7%

01/15/20

3.54%

Johnson & Johnson

3.5%

05/15/21

3.55%

Kimberly-Clark (NYSE: KMB)

4.1%

03/01/21

3.65%

Merck (NYSE: MRK)

4.1%

01/15/21

3.85%

Southern (NYSE: SO)*

4.7%

10/01/20

3.76%

Source: Finra.org. *Bonds issued by subsidiary Alabama Power.

In each of these cases, the stock of the issuer looks like an attractive alternative to the corresponding bond for income investors. Like any screen results, this list is a starting point for further research, not a recommendation to buy the stock.

Stocks aren't bonds, and the risk profiles are different. Shareholders face market risks, and companies can cut dividends, make dilutive stock offerings, or make ill-advised acquisitions. Bondholders face interest rate risk -- if rates rise, bond values will drop -- as well as credit risk.

At today's market prices, I think interest rate risks for high quality bonds aren't reflected in the prices and that the bond-versus-stock playing field is tilted in favor of stocks for many companies. That doesn't mean investors should ignore bonds, but they should consider stocks for at least part of an income-oriented portfolio.

You can follow any of the stocks mentioned using our free watchlist service, My Watchlist.

Fool contributor Russ Krull owns shares of Johnson & Johnson and Southern but has no financial position in any other companies mentioned in this article. The Motley Fool owns shares of Abbott Laboratories and Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of Abbott Laboratories, Kimberly-Clark, Johnson & Johnson, and Southern, as well as creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$166.72 (0.33%) $0.54
Merck & Co., Inc. Stock Quote
Merck & Co., Inc.
MRK
$86.78 (-0.83%) $0.73
Kimberly-Clark Corporation Stock Quote
Kimberly-Clark Corporation
KMB
$120.29 (-0.35%) $0.42
ConocoPhillips Stock Quote
ConocoPhillips
COP
$100.59 (-8.60%) $-9.47
The Southern Company Stock Quote
The Southern Company
SO
$74.99 (-1.25%) $0.95
Abbott Laboratories Stock Quote
Abbott Laboratories
ABT
$100.68 (-0.39%) $0.39
Colgate-Palmolive Company Stock Quote
Colgate-Palmolive Company
CL
$75.53 (0.23%) $0.17

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.